Skin Responses Differ Among Patients With Seborrheic Dermatitis and Rosacea
Skin responses to lactic acid sting and capsaicin tests varied, according to researchers.
Organization Empowers Communities, Individuals to Celebrate the Skin They Are In
Celebrating the Skin We're In seeks to advocate for health equity through community outreach and education efforts.
Decreased Levels of Vitamin D Share Linear Link With Psoriasis Severity
These findings come from one of the largest related studies to date.
Genetic Variations May Play Role in Acne Vulgaris, According to Lipid Profile Variation Estimates
Researchers found that lipid profile levels were higher in patients with acne vulgaris compared to otherwise healthy patients.
1 in 3 Dermatologists Do Not Counsel Patients With HS on Wound Care
Furthermore, a survey showed that more than half of providers do not discuss clothing modifications, and half report providing patients with wound care supplies that are covered by insurance.
Skin Microbiome Diversity Lower With Soap and Water Compared With Hand Sanitizer Use
Using hand washing and alcohol-based hand sanitizer use during the COVID-19 pandemic as a baseline, researchers evaluated the effects of these behaviors on the skin’s microbiome.
Systemic Oxidative Stress Plays Role in Etiopathogenesis of Melasma
Researchers noted that serum levels of malondialdehyde and vitamin C are indicators of the impairment caused by systemic oxidative stress.
Guselkumab, Ustekinumab Led to 2 Years of Sustained Improvements in Patients With Psoriasis
In the PERSIST study, improvements were sustained through week 104.
AAD, Janssen, and Kenvue Partner to Mentor Next Generation of Dermatologists
Daphne Chan, PhD, MHEcon, discusses the Pathways program, a partnership between the AAD, Janssen, and Kenvue to mentor young, aspiring dermatology providers.
Derm In The News: July 16-22
Keep up with the latest headlines in dermatology from the past week, including Novan, Inc.'s bankruptcy filing, rates of melanoma in European Union countries, and more.
Grant Program Accepting Applications, Seeks to Bridge Care Gap in Inflammatory Dermatoses
Grant applications are open from now until August 24, 2023, with an anticipated project start/end date of January 2024 through July 2025.
Real-World Cohort Study to Compare Efficacy and Safety of Adalimumab Biosimilars for Psoriasis
Study results are expected to be presented at international dermatology conferences by the end of the year.
Single-Strain Probiotic Has Positive Effect on Atopic Dermatitis in Pediatric Patients
Researchers conducted a systematic review and meta-analysis of probiotic treatment efficacy in children with atopic dermatitis.
Ruxolitinib Offers Rapid Pruritus Reduction
Clinicians James Q. Del Rosso, DO; Raj Chovatiya, MD, PhD; and Lisa Swanson, MD, PhD, review the study, “Rapid Pruritus Reduction With Ruxolitinib Cream in Patients With Atopic Dermatitis."
GlobalSkin’s GRIDD Study Seeks to Evaluate Global Impact of Skin Diseases
Researchers anticipate that upwards of 10,000 adults with various dermatologic conditions will partake in the study.
Ritlecitinib Performed Well in Adolescent Cohort Analysis of ALLEGRO Trial
Researchers conducted a subgroup analysis of the ALLEGRO phase 2b/3 clinical trial to evaluate the safety and efficacy of the drug in patients aged 12-17.
Addressing Disparities in AD With Telehealth
Adam Friedman, MD, FAAD, and Andrew Alexis, MD, MPH, discuss disparities in atopic dermatitis and the ways these can be addressed with teledermatology.
UCB Announces European Union Regulatory Application for Bimekizumab in Hidradenitis Suppurativa
If approved, hidradenitis suppurativa would be the 4th indication for the drug within the European Union.
ReachRX: Advancing Patient Outcomes Through Ease of Access to Treatment Information
Co-founders Jeff DeVico and Patrick DePippo discuss their app, ReachRX, which aspires to transform the dermatology and medical landscape through streamlined access to pharmaceutical information.
Revian Reports Promising Results in Initial Study for Hair Regrowth System
The aesthetic medical technology company announced that its hair regrowth system will be used in a second study.
Derm In The News: July 9-15
Keep up with the latest headlines in dermatology from the past week, including melanoma prevalence in Black men, local and statewide initiatives for skin cancer screening and prevention, and more.
Alopecia Areata Leads to Cost, Time Burdens in Cohort of Patients From Japan
Real-world data demonstrated marked impacts on the economy on a national and personal level.
Study Investigates Secukinumab’s Effects on Cytokines in Patients With Psoriasis
IL-17A was antagonized by secukinumab, while several other serum levels were decreased in expression.
Influencing and Improving Photoprotection Behaviors in Patients With Xeroderma Pigmentosum
Patients with the rare autosomal recessive genodermatosis are prone to extreme photosensitivity and changes in skin pigmentation.
Soligenix Expands Synthetic Hypericin Psoriasis Study
Additional patients will be enrolled in the phase 2a study after a clear biological signal was demonstrated in initial participants.
Microneedling Produces Beneficial Acne Vulgaris Outcomes Without Disrupting Skin Structure or Microbiome
Researchers sought to challenge the perception of microneedling as disruptive to the skin and disease states.
Pediatric Necrobiosis Lipoidica Yields Treatment Failure Rate of 40%
Researchers conducted a review of treatments for the rare disease in the pediatric population.
AD Patient Self-Confidence and Satisfaction Improved With Dupilumab Self-Injection
Dupilumab self-injection has been available to patients in Japan since May 2019.
Blue Light Irradiation Induces Minimal Pigmentation Change in Patients With Melasma
Compared to patients without melasma, blue light irradiation caused minimal changes in patients with melasma.
The Weekly Roundup: July 2-8
ICYMI, this week we had stories about burn management and treatment in light of the July 4 holiday, pearls from the 2023 World Congress of Dermatology meeting in Singapore, acral lentiginous melanoma in AAPI patients, and more.